Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract. The Cochrane database of systematic reviews (11). CD008811.
Data collection and analysis
Data were collected independently by two authors. We aimed to collect data on presenting visual acuity 6/12 or better and best-corrected visual acuity of less than 6/60 at three months and one year after surgery. Other outcomes included intraoperative complications, longterm complications (one year or more after surgery), quality of life, and cost-effectiveness. There were not enough data available from the included trials to perform a meta-analysis.
Main results
Three trials randomly allocating people with age-related cataract to MSICS or ECCE were included in this review (n = 953 participants). Two trials were conducted in India and one in Nepal. Trial methods, such as random allocation and allocation concealment, were not clearly described; in only one trial was an effort made to mask outcome assessors. The three studies reported follow-up six to eight weeks after surgery. In two studies, more participants in the MSICS groups achieved unaided visual acuity of 6/12 or 6/18 or better compared to the ECCE group, but overall not more than 50% of people achieved good functional vision in the two studies. 10/806 (1.2%) of people enrolled in two trials had a poor outcome after surgery (best-corrected vision less than 6/60) with no evidence of difference in risk between the two techniques (risk ratio (RR) 1.58, 95% confidence interval (CI) 0.45 to 5.55). Surgically induced astigmatism was more common with the ECCE procedure than MSICS in the two trials that reported this outcome. In one study there were more intra-and postoperative complications in the MSICS group. One study reported that the costs of the two procedures were similar.
Authors' conclusions
There are no other studies from other countries other than India and Nepal and there are insufficient data on cost-effectiveness of each procedure. Better evidence is needed before any change may be implemented. Future studies need to have longer-term follow-up and be conducted to minimize biases revealed in this review with a larger sample size to allow examination of adverse events.
P L A I N L A N G U A G E S U M M A R Y

Comparison of two different methods of lens removal in cataract surgery, particularly relevant to lower income settings
Review question
What is the best way of removing the lens in cataract surgery, especially in lower income settings?
This review considers two ways of removing the lens. In manual small incision surgery (MSICS) the lens is broken up and removed through a small incision. In extracapsular cataract extraction (ECCE) the lens is removed through a larger incision. ECCE is the standard way of doing cataract surgery in lower income countries.
Background
As people get older, the lens in the eye can become cloudy -this is known as a cataract. Cataract is the most common cause of blindness in the world. Vision can be restored by surgery to remove the cloudy lens. The lens is replaced with a plastic lens. This is known as an intraocular lens or IOL.
We judged the quality of the evidence to be low or very low. There were only three studies and we could not combine the data because of differences in reporting and inconsistency between trials which meant that some of the results were imprecise.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
MSICS 
B A C K G R O U N D
Description of the condition
Age-related cataract is the opacification of the lens, which occurs as a result of denaturation of lens proteins and this is not thought to be reversible. These changes are often bilateral although they can be asymmetric. Symptoms from cataracts include glare, blurred vision, progressive decrease in visual function and blindness.
Description of the intervention
Extracapsular cataract extraction (ECCE) was introduced with the development of microsurgical instrumentation in the early 1980s. The lens content is removed through a large 12 mm incision leaving the posterior lens capsule intact. A posterior chamber intraocular lens (IOL) can then be placed in the capsular bag (Apple 1989; Duane 1986). If no IOL is implanted, aphakic glasses or contact lenses must be used. Extracapsular surgery has become the preferred method of extraction in economically advantaged countries and most surgeons in developing countries have been trained in this technique. Further technological development has led to a majority of surgeons in developed countries adopting sutureless ECCE surgery (Norregaard 1999). This surgery uses either ultrasonic fragmentation (phacoemulsification) of the lens nucleus (Mehta 1999), or a manual fragmentation technique (Blumenthal 1992; Hennig 1999). Both suture and sutureless ECCE leave in place the posterior capsule of the lens. This keeps the anatomical barrier between the posterior and anterior segments of the eye and may reduce the risk of posterior segment complications. The disadvantage of all the extracapsular techniques is that the posterior lens capsule can become cloudy (Apple 1992) with the need for a primary or secondary capsulotomy by surgery or using a YAG laser. This increases the costs of surgery and incurs the risk of secondary complications (Javitt 1992). Manual small incision cataract surgery (MSICS) was first described by Blumenthal (Blumenthal 1992). In Asia and Africa there has been a renewal of interest in this technique (Ruit 2000) as an alternative to phacoemulsification because it is considerably less costly but has similar benefits of rapid visual recovery and reduced astigmatism (Yorston 2005). It involves a 6 mm to 6.5 mm scleral incision, just large enough to allow insertion of a 6 mm IOL. There are various different techniques described for performing the capsulotomy in MSICS, for example, the can-opener (Gogate 2005), the continuous curvilinear capsulorhexis (Gogate 2003) and the endocapsular technique where the incision is from pupil margin to pupil margin. The cataract is delivered into the anterior chamber, hydroextracted and aspirated. The posterior capsule of the lens is left intact. This technique is technically more difficult than a standard manual ECCE. Figure 1 is a flow diagram summarising the different types of cataract surgery. 
How the intervention might work
Cataract surgery works by removing the opacified lens and replacing it with a clear lens called an IOL. IOLs can be made from a range of materials, and they can be made of varying size, shape and refractive powers. Before cataract surgery the eye to be operated on is measured so that an IOL of the correct power (strength) can be inserted after the cataract has been removed. The IOL is usually placed inside the "bag" of the lens capsule inside the eye. Other options for lens replacement include contact lenses and glasses. Surgery is currently the only treatment option once the lens has opacified and vision is decreasing. The indication for surgery is based on whether the patient's reduced visual function interferes with their quality of life.
Why it is important to do this review
The World Health Organization (WHO) recently reported that age-related cataract is now responsible for 48% of world blindness, which represents about 18 million people currently. It was estimated that there were 37 million people worldwide who were blind in 2002 (Passolini 2004; Resnikoff 2004). Age-related cataract remains the leading cause of blindness globally, except in the most developed countries. This is despite an increasing number of visually impaired and blind people gaining access to cataract surgical services due to the development of prevention of blindness programmes in many countries (Kupfer 1994). Despite these positive trends the number of people blind due to cataract is increasing because of the changing demographic structure of populations (Limburg 1996; Minassian 1990; Thylefors 1998). More than 82% of all blind people are 50 years of age or older. It is estimated that the present number of 20 million cataract blind will double by the year 2020. The global initiative "Vision 2020: The Right to Sight" has suggested various strategies to reduce cataract blindness (Foster 2001). The WHO has called for a dramatic increase in surgical volumes worldwide, but the outcomes of cataract surgery are not always good and may depend on the surgical technique used (Venkatesh 2005). The first published version of this review 'Surgical interventions for age-related cataract' (Snellingen 2002) compared the outcomes of different cataract surgical techniques. The techniques included initially were intracapsular extraction (ICCE), ECCE and phacoemulsification. In 2006 the review was revised and a fourth surgical technique MSICS was added to the review (Riaz 2006). Following consultation with the review authors and the Cochrane Eyes and Vision Group this update has been divided into three smaller reviews each using the same outcome measures but only comparing two surgical methods within each review. The ICCE technique is no longer included as this method is no longer used as a primary procedure.
The cataract surgical techniques compared in these three reviews are: 1. MSICS and ECCE (current review); 2. phacoemulsification and ECCE (de Silva 2014); 3. phacoemulsification and MSICS (Riaz 2013). Although phacoemulsification is the most technologically advanced method providing small incision sutureless surgery, it requires considerable resources due to consumables, maintenance and training of surgeons. It is the procedure of choice for cataract surgery in developed countries. From a global perspective phacoemulsification is too costly for many developing countries where there is the highest incidence of cataract blindness. Manual small incision surgery and ECCE are alternative techniques available at a lower cost. The aim of this review is to compare the relative effectiveness of ECCE and MSICS. This review will help to establish which surgical method (MSICS or ECCE) should be performed for people with age-related cataract, especially those living in low and middle-income countries, where high volumes of cataract surgeries are performed.
O B J E C T I V E S
The aim of this review is to compare two different techniques of lens removal in cataract surgery: MSICS and ECCE.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) only.
Types of participants
Participants in the trials were people with age-related cataract.
Types of interventions
We included trials where MSICS with a posterior chamber IOL implant was compared to ECCE with a posterior chamber IOL implant. We also considered the different ways in which the lens was removed in MSICS or ECCE. We defined these as:
• techniques requiring the placement of sutures;
• techniques not requiring the placement of sutures with the lens removed after manual fragmentation.
We did not consider phacoemulsification in this review as this is the subject of the two separate Cochrane reviews (de Silva 2014; Riaz 2013) mentioned above.
Types of outcome measures
Primary outcomes
The primary outcome for this review was postoperative visual acuity. We considered both presenting* and best-corrected visual acuity (BCVA) at the following cut-points.
• Proportion of people achieving good functional vision defined as presenting visual acuity better than or equal to 6/12 in the operated eye.
• Proportion of people with a poor outcome after surgery defined as BCVA worse than 6/60 in the operated eye.
* Presenting visual acuity is vision that the person uses in normal life, i.e. with or without glasses, if worn. 
Follow up
We considered outcomes at three months and one year after surgery. As studies may not report outcomes exactly at these time points we defined the following time periods:
• three months: from four weeks to less than six months • 12 months: from six months to less than 18 months 
Search methods for identification of studies
Searching other resources
We searched the reference lists of all included studies and pertinent reviews identified. We contacted the authors of the included studies to identify unpublished studies or studies sent for publication or in press.
Data collection and analysis
Selection of studies
Two authors assessed the search results for relevance and inclusion. We obtained full-text copies of any report referring to definitely or possibly relevant trials. We assessed these full-text copies according to the definitions in the 'Criteria for considering studies for this review' section. We only assessed trials meeting these criteria for methodological quality. Any trial that was excluded at this stage, was documented in the review and a reason for exclusion given.
Data extraction and management
We extracted data using a form developed by the Cochrane Eyes and Vision Group. Two authors extracted data and compared the results for differences. We resolved discrepancies by discussion.
One author entered data in to Review Manager 5 (Review Manager 2011) and the second author checked for errors.
Assessment of risk of bias in included studies
We assessed the included studies using the Cochrane Collaboration's tool for risk of bias as described in Chapter 8 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). We considered the following parameters: sequence generation and allocation concealment, masking (blinding) of participants, personnel and outcome assessors, incomplete outcome data, selective outcome reporting and other sources of bias. We graded them as low risk of bias, high risk of bias, and unclear risk of bias indicating either lack of information or uncertainty over the potential for bias. Two review authors independently assessed the risk of bias for each of these parameters and disagreement was resolved by discussion. Authors were not masked to the report authors and trial results during the assessment.
Measures of treatment effect
The outcomes for this review are largely dichotomous (i.e. postoperative visual acuity and complications). Our measure of treatment effect is the risk ratio. For outcomes that occur rarely (in less than 10% of the cohort), we planned to use the odds ratio. We planned to analyse quality of lIfe, which may be reported as a continuous variable, using the weighted mean difference, but in the event no data were available on quality of life.
Unit of analysis issues
The main unit of analysis issue is how the trial investigators dealt with the fact that people have two eyes. There are several options here: a trial may randomise people to the intervention groups and then apply the intervention and/or measure the outcome in one eye (study eye) or both eyes. In the latter case it is incorrect to analyse eyes without taking into account the fact that the eyes for a person are not independent. Alternatively a trial may randomly allocate eyes to an intervention so each person has a different intervention in each eye. In this case, the pairing has to be taken into account in the analysis. In our protocol we planned the following:
At the review level, if the trial has been incorrectly analysed, we will contact the trial investigators for further information to enable calculation of a design effect (Perera 2007). If the trial does report estimates adjusted for within person correlation we will enter them in the review using the generic inverse variance method. Although cluster trials are a possibility we think they are unlikely because individual randomisation is relatively easy to do in this case. However, we did not have enough data to include this in any formal meta-analysis. Only Gurung 2009 mentioned that 100 eyes of 88 participants were randomised into two groups. For the other two trials it was unclear from the study report but contact with the investigators of Gogate 2003 confirmed only one eye per person was entered into the trial.
Dealing with missing data
We planned to collect data on the reason for missingness, with the caveat that this might not be reliably reported. Our plan to deal with missing data was as follows but in the event we did not have enough data for any formal meta-analysis: Analyses based on available data assume that missing data are missing at random. We will investigate how reasonable this assumption is by doing a series of sensitivity analyses with different assumptions about the missing data using methods as set out by White et al (White 2008).
The "informative missingness odds ratio" (IMOR) refers to the ratio of the odds of the outcome among participants for whom data are missing and the odds of the outcome among participants who are available. These IMORs can be assumed to be equal or different in the two trial arms. We plan to do four sensitivity analyses. Firstly we will assume the IMOR is 2 in treatment and control groups i.e. that people who were not seen were twice as likely to have the outcome. Secondly, we will assume that the IMOR was ½ in both treatment and control groups i.e. that people who were not seen were half as likely to have the outcome. For the third and fourth sensitivity analyses, we will assume that the IMOR was opposite in treatment and control groups -i.e. 2 or ½. All analyses will be done using the metamiss command in Stata (version 11.0, StataCorp LP, 4905 Lakeway Drive, College Station, TX 77845 USA). If the pooled risk ratio in any of these sensitivity analyses differs substantially from the available case analysis (say by 10% or more) it is likely that the missing data in the included trials are a cause for concern. We will record this information in the risk of bias tables under "incomplete data".
Assessment of heterogeneity
Our plan for assessing heterogeneity was as follows but in the event we did not have enough data for any formal meta-analysis:
We will assess heterogeneity in several ways. Firstly, by documenting clinical and methodological differences between the studies. Secondly by examining the forest plots to see whether the estimates of effect are consistent, and thirdly by considering the I 2 value and χ 2 test for heterogeneity (bearing in mind that the χ 2 test has low power when the number of trials is small).
Assessment of reporting biases
Our plan for assessing reporting biases was as follows but in the event we did not have enough data to complete these:
The main reporting biases that we will consider are publication bias and outcome reporting bias. For publication bias, if there are enough trials we will do a funnel plot to assess whether small trials have different effects. To assess outcome reporting bias we will complete a review outcome matrix following the ORBIT classification (Kirkham 2010).
Data synthesis
Our plan for assessing data synthesis was as follows but in the event we did not have enough data for a formal meta-analysis:
We will pool data from studies collecting comparable outcome measures with similar follow-up times using a random-effects model (unless there are three or fewer trials in which case we will use a fixed-effect model).
If there is evidence for substantial heterogeneity or inconsistency, for example an I 2 value of 50% or more, we will not pool the results. The outcomes for this review include a number of complications. Initially we will tabulate these data only. For outcomes that are commonly reported we will go on to do a meta-analysis in order to provide a summary estimate of risk.
Subgroup analysis and investigation of heterogeneity
Our plan for subgroup analysis was as follows but in the event we did not have enough data for a formal subgroup analysis: It is possible that the effect of the interventions will vary according to the setting (high/low volume) and whether or not suture/sutureless techniques are used. If there are enough data, we will explore heterogeneity focusing primarily on these subgroups.
Sensitivity analysis
Our plan for sensitivity analysis was as follows but in the event we did not have enough data for a formal sensitivity analysis:
If there are enough trials contributing to the meta-analyses we will investigate the effect of excluding poorer quality trials. In particular, we will investigate the effect of excluding trials where allocation concealment was not properly reported and where there was no masking of outcome assessment.
R E S U L T S Description of studies
Results of the search
The electronic searches yielded a total of 148 titles and abstracts.
After de-duplication we screened the title and abstracts of 103 references. We rejected 100 abstracts as not eligible for inclusion in the review. We obtained and screened full-text copies of three references and included them in the review. An update search run in September 2014 identified a further 33 references ( Figure 2 ). The Trials Search Co-ordinator removed 14 duplicates and screened the remaining 19 references, of which eight were not relevant to the scope of the review. We reviewed the remaining 11 references and but none met the inclusion criteria for the review. 
Included studies
We included three trials (George 2005; Gogate 2003; Gurung 2009) that met our inclusion criteria. We have provided a brief summary of the characteristics of the included studies and further details can be found in the 'Characteristics of included studies' table. 
Size of study
Types of interventions
All three studies compared MSICS with ECCE; in one trial there was an additional phacoemulsification arm (George 2005).
Follow-up
All three studies had a minimum follow-up of six weeks. None of the trials reported data after eight weeks. For Gogate 2003 this was confirmed by contact with the investigator.
Outcomes
All three studies evaluated visual acuity and astigmatism as their main outcome; and complications as part of results of the study.
Allocation
In only one trial was it clearly stated how the allocation schedule was generated (George 2005). One trial described using drawing lots or 'ballots' to randomly assign the treatment and surgeon (Gogate 2003). Allocation concealment was not described in any trial.
Blinding
In assessing ECCE and MSICS, it may be difficult to mask the assessors due to the obvious presence of sutures in ECCE. Nonetheless, masking was stated in one study where internee doctors and optometrists did postoperative visual acuity testing and administering the questionnaires; participants were not told about the type of surgery done (Gogate 2003).
Incomplete outcome data
Follow-up rates were good in all three trials: 85% (George 2005); 95% (Gogate 2003) and 100% (Gurung 2009) respectively. Exclusions were not clearly documented except in one trial (Gogate 2003).
Selective reporting
Postoperative complications were not described in the George 2005 study. Otherwise, all outcomes on visual acuity, astigmatism and complications were reported in all three studies.
Other potential sources of bias
In one trial, some surgeons performed more surgeries of one kind to increase the external validity of the study. Imbalance of surgeon assignment may have introduced bias, but this was dealt with by stratification by surgeon in the analysis (Gogate 2003).
Effects of interventions
See: Summary of findings for the main comparison
Visual outcomes
The data on visual outcomes is summarised in 
Endothelial cell count
Gogate 2003 and Gurung 2009 did not study this outcome. In George 2005, there was no statistically significant difference in endothelial cell loss between the MSICS and ECCE groups. The sample size was adequate to detect a 7% difference in endothelial cell count between the groups, giving a power of 80%. There was a mean 4.72% (N = 52, SD 13.07) induced cell loss in ECCE at six weeks follow-up compared with 4.21% (N = 53, SD 10.29) for MSICS.
Economic evaluation
In the PUNE study (Gogate 2003), there was no significant difference in surgical time or cost between the two procedures, even accounting for surgeon variation. The average cost of ECCE was USD 15.82, MSICS USD 15.68 of which USD 11.34 was a fixed facility cost common to both.
D I S C U S S I O N
Summary of main results
Overall, visual outcomes are comparable between MSICS and ECCE ('Summary of findings for the main comparison'). Although MSICS have better UCVA results, there is no difference in BCVA between the two methods. However, surgically induced astigmatism is significantly greater after ECCE compared to MSICS. There is suggestion that there are fewer intraoperative and postoperative complications after ECCE than MSICS but this requires further study based on the quality of evidence supporting this. Thus, in countries such as India where high surgical volumes are required, MSICS was suggested to be the surgical technique of choice due to better unaided visual outcomes but equal costs.
Overall completeness and applicability of evidence
As most study participants came from India or Nepal, the applicability to other populations or races may be limited. Moreover, within India there is a difference between the results from hospitals when compared to cataract camps (Singh 2000) , which should be kept in mind when interpreting these results. Furthermore, evaluation of cataract surgery outcomes should not be based on postoperative visual acuity alone -and assessments of quality of life and quality of vision should be made. The studies in this review did not specifically measure these outcomes.
Quality of the evidence
We included three trials in this review, which compared two techniques for cataract surgery. Due to the small number of studies that actually examined our objectives, conclusions have to be interpreted with caution. The main outcome measure was visual acuity in the studies reviewed. However, it is not appropriate to compare MSICS and ECCE at six weeks, as suture techniques such as ECCE require a longer period for vision stabilisation due to suture induced astigmatism. Only one study had a follow-up of up to one year (Gogate 2003) but did not report these data.
Although long-term follow-up is always a challenge in developing countries, more studies with a longer-follow-up are required.
Potential biases in the review process
All studies included were from an extensive search with the abovementioned search and inclusion criteria. However, only three studies were included out of the many studies reviewed. Studies not published and indexed in the libraries included, or non-English journals may have been omitted. While RCTs provide the highest level of evidence, cohort studies or observational studies could provide some information not included in this review. Finally, publication bias may exist if only studies with significant results are published, however, we did not have direct evidence of any publication bias in this case.
Agreements and disagreements with other studies or reviews
When evaluating cataract surgeries, cost-effectiveness is an important outcome measure not studied frequently. In our review, included studies suggested that MSICS had better unaided visual acuity and equal cost. Another study not included in this review found that MSICS (USD 17.03) cost more than ECCE (USD 16.25) (Muralikrishnan 2004), but patients' costs (direct and indirect) were highest for ECCE due to the increased number of days required for follow-up, which incurs transportation and economic productivity loss. However, it is unclear if this study was adequately powered to study this and clearly, the need for a proper cost-effectiveness study is required.
A U T H O R S ' C O N C L U S I O N S
Implications for practice
This review, which only includes three RCTs, suggests that MSICS gives better uncorrected visual acuity and less surgically induced astigmatism compared to ECCE. Each surgical technique has its limitations, and should be chosen based on patients' medical and ocular history. For example, relative contraindications to MSICS include zonular weakness, lack of corneal clarity with corneal decompensation and dense cataracts. There are no other studies from other countries other than India and Nepal and there are insufficient data on cost-effectiveness of each procedure. Better evidence is needed before any change may be implemented.
Implications for research
More studies are required to compare the visual outcomes between MSICS and ECCE. We suggest that visual outcomes at three and six months are the minimum follow-up time for comparing ECCE and MSICS. Also, an adequately powered randomised controlled trial is required to assess cost-effectiveness and the impact on quality of life. When executing these RCTs the study participant should be randomised to expert surgeons in each technique rather than having the same surgeon performing both procedures to reduce single surgeon bias. A single surgeon performing both procedures does not produce a surgeon effect. This is bias introduced by a surgeon having more expertise in one intervention as compared to the other.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Gogate 2003 (Continued)
There was always a 50% chance of the patient getting one particular kind of intervention." Page 669
Allocation concealment (selection bias) Low risk "The operating surgeons also drew ballots for the type of surgery they were supposed to do that day, at the beginning of the theatre list immediately before scrubbing. This random assignment was done in the presence of the anaesthetist, operation theatre senior nurse, and another non-operating ophthalmologist. " Page 669
Blinding of participants and personnel (performance bias) All outcomes
Low risk "The patients were not informed as to the type of intervention they would receive, in the OT and during follow up. The surgeons were unaware until scrubbing up which surgery they would perform that day. They were also unaware which patient would be brought to them for surgery and did not examine the patients the next day." Page 669
Blinding of outcome assessment (detection bias) All outcomes Other bias Unclear risk Some surgeons performed more surgeries of one kind if the operating list was more compared to the other technique when the list was shorter. This was done to increase the external validity of the study. Imbalance of surgeon assignment may have introduced bias, but this was dealt with by stratification by surgeon in the analysis 22
Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract (Review) Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. D A T A A N D A N A L Y S E S
This review has no analyses. BCVA: best-corrected visual acuity * In the protocol for the review we planned to measure outcomes at three months which we defined as any assessment between 4 weeks and 6 months. In fact both trials contributing data measured visual acuity a bit earlier than 3 months at six weeks (Gogate 2003) and six to eight weeks (Gurung 2009). **In the protocol for the review, we planned to examine "presenting" vision but in fact both trials reported unaided or uncorrected vision here and Gogate 2003 only reported visual acuity of 6/18 or better. *** Data from Gogate 2003; Gurung 2009 were inconsistent (I 2 = 59%) therefore were not pooled. 
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Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract (Review) Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
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